News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Videos|February 16, 2022

Coming Soon: Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma

Author(s)Ryan Haumschild, PharmD, MS, MBA

Episodes in this series

multiple myeloma

EP. 1 Coming Soon: Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma

EP. 2 A Multiple Myeloma Overview

EP. 2 A Multiple Myeloma Overview

EP. 3 MM and Regimens for First- and Second-Line Treatment

EP. 3 MM and Regimens for First- and Second-Line Treatment

EP. 4 MM From the Payers’ Perspective

EP. 4 MM From the Payers’ Perspective

EP. 5 MM Healthcare Resource Utilization

EP. 5 MM Healthcare Resource Utilization

EP. 6 Decision Support Tools for MM

EP. 6 Decision Support Tools for MM

EP. 7 MM and the Limitations of RCT Data

EP. 7 MM and the Limitations of RCT Data

EP. 8 MM and Real-World Evidence

EP. 8 MM and Real-World Evidence

EP. 9 The Value of RWE in MM

EP. 9 The Value of RWE in MM

EP. 10 Incorporating RWE in MM Decision-Making

EP. 10 Incorporating RWE in MM Decision-Making

EP. 11 RWE Decision-Making Barriers

EP. 11 RWE Decision-Making Barriers

EP. 12 MM and Non-Comparative RWE

EP. 12 MM and Non-Comparative RWE

EP. 13 Educating on RWE

EP. 13 Educating on RWE

EP. 14 MM Unmet Needs

EP. 14 MM Unmet Needs

EP. 15 Incorporating RWE Into Future Decision-Making

EP. 15 Incorporating RWE Into Future Decision-Making

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

First-line anlotinib plus chemotherapy demonstrates favorable efficacy and manageable toxicity in advanced STS. | Image credit: @Aidman-Adobestock.jpeg

Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma

BySabrina McCrear

January 23rd 2026

Mitzi Wasik, PharmD, MBA, BCPS, FAMCP, FCCP, executive director of the AMCP Foundation and senior vice president of Practice Strategy and Innovation at AMCP | Image credit: AMCP

RWD Is Transforming Mental Health, Neurology Managed Care: Mitzi Wasik, PharmD

ByRose McNulty,Mitzi Wasik, PharmD, MBA

January 22nd 2026

computer-generated lungs | Image Credit: Rasi - stock.adobe.com

Oral Nalbuphine Significantly Reduces Chronic Cough in IPF

BySabrina McCrear

January 22nd 2026

Mantle Cell Lymphoma | Image: Perla Vicari, MD, PhD, ASH Image Bank

In Mantle Cell Lymphoma, Not all TP53 Mutations Are Created Equal

January 22nd 2026

Early Data Show Feasibility of in Vivo CAR T Therapy in Multiple Myeloma

ByKrina Patel, MD, MSc

January 22nd 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Trending on AJMC

Novel CLL Therapies Prompt New Treatment Considerations

Congress Unveils Massive Funding Bill to Avert Shutdown

Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma

Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access

Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.